Hypoparathyroidism Market is Expected to Exhibit Impressive Growth by 2032, Assesses DelveInsight | Leading Companies Developing Therapies - Ascendis Pharma, Amolyt Pharma, Bridgebio, Calcilytix Therapeutics New York, USA, Feb. 05, 2024 (GLOBE NEWSWIRE) -- Hypoparathyroidism Market is Expected to Exhibit Impressive Growth by 2032, Assesses DelveInsight | Leading Companies Developing Therapies - Ascendis...

Hypoparathyroidism Treatment Market is projected to hit US$ 1,767.4 Million by 2033, exhibiting a CAGR of 7.7% over the forecast period | Future Market Insights, Inc. NEWARK, Del, May 25, 2023 (GLOBE NEWSWIRE) -- The Hypoparathyroidism Treatment Market was estimated to be worth US$ 777.4 million in 2022 and is anticipated to grow to US$ 841.9 million in 2023. The...